[Federal Register Volume 74, Number 158 (Tuesday, August 18, 2009)]
[Page 41710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-19788]



Food and Drug Administration

[Docket No. FDA-2008-N-0637]

Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Financial Disclosure by Clinical 

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.


SUMMARY:  The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Financial Disclosure by Clinical 
Investigators'' has been approved by the Office of Management and 
Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Elizabeth Berbakos, Office of 
Information Management (HFA-710), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, [email protected], 301-

SUPPLEMENTARY INFORMATION: In the Federal Register of April 22, 2009 
(74 FR 18385), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0396. 
The approval expires on August 31, 2012. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.reginfo.gov/public/do/PRAMain.

    Dated: August 11, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-19788 Filed 8-17-09; 8:45 am]